Release date: 2 December 2013
Promoter – Financial Intermediary
HollandPTC B.V.Location
Description
New research-focused proton therapy (PT) centre in Western Holland promoted by Delft University of Technology, Leiden University Medical Centre and Erasmus University Medical Centre Rotterdam.
Objectives
The project consists of the construction and development of a new proton therapy research centre jointly promoted by three leading universities in the Netherlands: Erasmus University Medical Centre Rotterdam, Leiden University Medical Centre and Delft University of Technology. Their joint-venture for this project is named Holland PTC and aims at assessing the efficacy of proton technology by conducting basic and clinical research. At least 600 cancer patients will be included annually in clinical studies. The centre is expected to be built in the Delft University of Technology’s science park and be functional from 2016 onwards. EIB will be involved in the financing of both the centre and the research and development (R&D) investment programme which will be carried out at HollandPTC.
Sector(s)
Proposed EIB finance (Approximate amount)
EUR 90 million
Total cost (Approximate amount)
EUR 120 million
Environmental aspects
The Nuclear Energy Permit, including Environmental Impact section, has been granted to Technische Universiteit Delft (TUD) for the Holland Particle Centre BV.
Procurement
The Bank will require the promoter to ensure that contracts for the implementation of the project shall be awarded in conformity with EU Public Procurement Directive 2004/18/EC.
Status
Signed - 9/05/2014
Disclaimer
Before financing approval by the Board of Directors, and before loan signature, projects are under appraisal and negotiation. The information and data provided on this page are therefore indicative.
They are provided for transparency purposes only and cannot be considered to represent official EIB policy (see also the Explanatory notes).